IC
VNDA icon

IEQ Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

IEQ Capital’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
282,779
+124,709
+79% +$815K 0.01% 866
2026
Q1 		$1.09M Buy
158,070
+127,000
+409% +$979K 0.01% 1002
2025
Q4 		$274K Sell
31,070
-20,808
-40% -$115K ﹤0.01% 1574
2025
Q3 		$259K Buy
51,878
+40,509
+356% +$188K ﹤0.01% 1580
2025
Q2 		$53.7K Buy
+11,369
New +$49.7K ﹤0.01% 1761

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's VNDA Position: Q2 2026 in Review

IEQ Capital increased its Vanda Pharmaceuticals (VNDA) stake by 79% in Q2 2026, buying an estimated $815K and bringing the position to 282,779 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #866.

IEQ Capital first reported a position in VNDA in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • IEQ Capital held 282,779 shares of Vanda Pharmaceuticals worth $1.73M as of Q2 2026.
  • IEQ Capital bought 124,709 Vanda Pharmaceuticals shares in Q2 2026, an estimated $815K.
  • Vanda Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #866 holding.
  • IEQ Capital first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.